CNN: Experimental Drug Remdesivir might Help Patients Recover More Quickly
Researchers released some good news about a possible treatment for coronavirus - evidence that the experimental drug remdesivir might help patients recover more quickly from the infection, CNN reports.
The US Food and Drug Administration has not yet approved any drugs for the treatment of the coronavirus. But it plans to announce an emergency-use authorization for remdesivir, reported The New York Times.
In a statement to CNN, the FDA said it is in talks with Gilead Sciences, the maker of remdesivir, about making the drug available to patients.
"As part of the FDA's commitment to expediting the development and availability of potential COVID-19 treatments, the agency has been engaged in ... discussions with Gilead Sciences regarding making remdesivir available to patients as quickly as possible, as appropriate," FDA spokesman Michael Felberbaum said in a statement.
“The government-funded study found that patients who took remdesivir recovered faster than patients who did not. It's not a home run, but federal officials are keen to provide any hope they can in a pandemic that has infected more than 1 million Americans and killed close to 60,000 of them,” reads CNN article written by Maggie Fox, Jamie Gumbrecht, Holly Yan and Betsy Klein.
The head of the National Institute of Allergy and Infectious Diseases was optimistic about the results.
"The data shows that remdesivir has a clear-cut, significant, positive effect in diminishing the time to recovery," Dr. Anthony Fauci said at the White House during a meeting with President Donald Trump.
Results from the preliminary trial show remdesivir improved recovery time for coronavirus patients from 15 to 11 days. That's similar to the effect that the influenza drug Tamiflu has on flu. Tamiflu also doesn't cure patients quickly but can reduce how long they are sick.
“Remdesivir also may reduce the likelihood that patients will die,” the article further reads.
Source: CNN
Read the full article here